Harvest Healthcare Ltd

harvesthealthcare.co.uk

Harvest Healthcare Ltd is the leading manufacturer and distributor of quality healthcare equipment to the NHS, Care Home and Community markets, throughout the UK and internationally. We are continually developing our range of products to deliver a complete solution for all modern care environments. Focused on meeting the ever-evolving needs of patients, Harvest deliver quality and value for money.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

PHARMABCINE TO PRESENT UPDATED INTERIM DATA FROM THE ONGOING PHASE IB TRIAL OF OLINVACIMAB AND PEMBROLIZUMAB COMBINATION THERAPY

PharmAbcine | December 08, 2020

news image

PharmAbcine Inc., a clinical-stage biotech organization focusing in on the improvement of completely human antibody therapeutics, declared today that the organization will introduce the refreshed break information from the continuous stage Ib trial of olinvacimab and pembrolizumab combination therapy in metastatic triple-negative breast cancer (mTNBC) patients at the 2020 San Antonio Breast Cancer Symposium (SABCS 2020) occurring for all intents and purposes over December 8-11, 2020.
Read More

Medical, Industry Outlook

GINKGO BIOWORKS AND THE GOVERNMENT OF THE REPUBLIC OF PANAMA ANNOUNCE PLANS TO ESTABLISH NEW BIOSECURITY CAPABILITIES

PRNewswire | August 07, 2023

news image

Ginkgo Bioworks the leading horizontal platform for cell programming and biosecurity, and the Government of the Republic of Panama's Gorgas Memorial Institute for Health Studies, today announced that they have entered into a Memorandum of Understanding ("MOU") with the intent to develop and implement new biosecurity capabilities in Latin America. Ginkgo, through its biosecurity and public health unit, Concentric by Ginkgo, aims to support the Gorgas Institute as it...

Read More

Medical

MOGRIFY ANNOUNCES EXPLORATORY RESEARCH COLLABORATION WITH MRC LABORATORY OF MOLECULAR BIOLOGY

Mogrify | January 11, 2021

news image

Mogrify Limited (Mogrify®), a UK organization expecting to change the advancement of ex vivo cell therapies and pioneer the field of in vivo reconstructing treatments, and the MRC Laboratory of Molecular Biology (LMB), a top notch research lab committed to understanding significant natural cycles at the sub-atomic level, today reported an exploratory examination cooperation. The venture intends to create novel protein articulation frameworks by utilizing late advances in direct cell reconstr...

Read More

MedTech

NEUMORA THERAPEUTICS ANNOUNCES $112 MILLION SERIES B FINANCING

Neumora | October 12, 2022

news image

Neumora Therapeutics, Inc. a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience, today announced the close of a $112 million Series B financing. The Series B syndicate includes both new and existing investors, such as Abu Dhabi Growth Fund Altitude Life Science Ventures, Amgen, ARCH Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, Polaris Partners and other und...

Read More
news image

Research

PHARMABCINE TO PRESENT UPDATED INTERIM DATA FROM THE ONGOING PHASE IB TRIAL OF OLINVACIMAB AND PEMBROLIZUMAB COMBINATION THERAPY

PharmAbcine | December 08, 2020

PharmAbcine Inc., a clinical-stage biotech organization focusing in on the improvement of completely human antibody therapeutics, declared today that the organization will introduce the refreshed break information from the continuous stage Ib trial of olinvacimab and pembrolizumab combination therapy in metastatic triple-negative breast cancer (mTNBC) patients at the 2020 San Antonio Breast Cancer Symposium (SABCS 2020) occurring for all intents and purposes over December 8-11, 2020.
Read More

news image

Medical, Industry Outlook

GINKGO BIOWORKS AND THE GOVERNMENT OF THE REPUBLIC OF PANAMA ANNOUNCE PLANS TO ESTABLISH NEW BIOSECURITY CAPABILITIES

PRNewswire | August 07, 2023

Ginkgo Bioworks the leading horizontal platform for cell programming and biosecurity, and the Government of the Republic of Panama's Gorgas Memorial Institute for Health Studies, today announced that they have entered into a Memorandum of Understanding ("MOU") with the intent to develop and implement new biosecurity capabilities in Latin America. Ginkgo, through its biosecurity and public health unit, Concentric by Ginkgo, aims to support the Gorgas Institute as it...

Read More
news image

Medical

MOGRIFY ANNOUNCES EXPLORATORY RESEARCH COLLABORATION WITH MRC LABORATORY OF MOLECULAR BIOLOGY

Mogrify | January 11, 2021

Mogrify Limited (Mogrify®), a UK organization expecting to change the advancement of ex vivo cell therapies and pioneer the field of in vivo reconstructing treatments, and the MRC Laboratory of Molecular Biology (LMB), a top notch research lab committed to understanding significant natural cycles at the sub-atomic level, today reported an exploratory examination cooperation. The venture intends to create novel protein articulation frameworks by utilizing late advances in direct cell reconstr...

Read More
news image

MedTech

NEUMORA THERAPEUTICS ANNOUNCES $112 MILLION SERIES B FINANCING

Neumora | October 12, 2022

Neumora Therapeutics, Inc. a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience, today announced the close of a $112 million Series B financing. The Series B syndicate includes both new and existing investors, such as Abu Dhabi Growth Fund Altitude Life Science Ventures, Amgen, ARCH Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, Polaris Partners and other und...

Read More